Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

NCT00806676 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: Gardasil® Vaccine (FDA-approved vaccination regimen)

Sponsor

Johns Hopkins University

Collaborators

[object Object]